{"filings":[{"id":453436,"accession_number":"0001193125-26-225491","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2026-05-15T13:06:29+00:00","items":["1.01","2.01","3.01","3.03","5.01","5.02","5.03","7.01","9.01"],"status":"ready","headline":"Enhabit acquired by Kinderhook for $13.80 per share; goes private","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquisition of Enhabit by Kinderhook completed at $13.80 per share; aggregate purchase price of approx. $762M.","Enhabit common stock delisted from NYSE; Company will file Form 15 to deregister and suspend SEC reporting.","All pre-Merger directors resigned; new board consists of Ryan Solomon, Dylan Black, and Julie Jolley.","Credit agreement amended: $105M incremental term loans added, revolver increased by $40M to $200M total."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":34161,"accession_number":"0001803737-26-000028","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2026-05-12T17:33:43+00:00","items":["5.07","8.01"],"status":"ready","headline":"Enhabit stockholders approve merger with Anchor Parent; closing expected May 15","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Merger proposal approved with 36,311,910 votes for, 18,275 against, 10,917 abstained.","Non-binding compensation resolution approved with 33,086,210 for, 3,030,210 against.","Parties intend to complete merger on May 15, 2026, subject to customary closing conditions.","Following merger, EHAB common stock will be delisted from NYSE and cease public trading."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.95,"calibrated_materiality_score":0.95,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95586,"accession_number":"0001193125-26-205181","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2026-05-05T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Enhabit supplements proxy disclosures amid three stockholder lawsuits challenging merger with Kinderhook","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["Three lawsuits filed Apr 21-28, 2026 in NY Supreme Court allege proxy omitted material info on financial projections and Goldman Sachs conflicts.","Supplemental disclosures add that no formal proposals were received after the May 2024 strategic review.","Termination fees disclosed: 1.5% of equity if Enhabit takes superior proposal during go-shop, 3.5% other terminations, 6% payable by Kinderhook.","Additional details provided on confidentiality agreements with parties A-G and Board sub-groups formed in Aug 2025 and Jan 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95585,"accession_number":"0001193125-26-159105","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2026-04-16T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Enhabit sets May 12 stockholder vote for Kinderhook acquisition; HSR waiting period terminated early","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Special meeting on May 12, 2026 at 8 a.m. CDT to adopt merger agreement with Anchor Parent, LLC (Kinderhook).","FTC granted early termination of HSR waiting period on April 15, 2026, satisfying key closing condition.","Merger expected to close in Q2 2026, subject to stockholder approval and remaining conditions.","Enhabit suspends earnings calls, financial guidance, and Q2 2026 earnings release due to pending transaction."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108754,"accession_number":"0001803737-26-000015","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2026-03-05T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Enhabit Q4 revenue $270.4M; Adj. EBITDA $28.0M; pending $13.80/share Kinderhook merger","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net service revenue $270.4M (+4.7% YoY); adjusted EBITDA $28.0M (+11.6% YoY).","Diluted loss per share $0.76; adjusted diluted EPS $0.14.","Home health admissions +7.3% YoY; hospice average daily census +9.9% YoY.","Pending acquisition by Kinderhook at $13.80/share ($1.1B EV), expected Q2 2026 close.","Reduced bank debt $15M in Q4; leverage ratio 3.7x; $125M debt reduction since Q4 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108753,"accession_number":"0001803737-26-000009","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2026-03-04T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Enhabit enters $475M credit facility ($315M term loan A, $160M revolver) maturing 2031","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$315M term loan A and $160M revolving facility, both due Feb 2031.","Initial SOFR margin 2.25%, ABR margin 1.25%; commitment fee 0.30%.","Proceeds refinance existing debt and fund general corporate purposes.","Covenants: total net leverage ≤4.50x, fixed charge coverage ≥1.25x.","Term loan amortizes quarterly at 1.875% of principal, starting June 30, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108752,"accession_number":"0001803737-26-000006","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2026-02-27T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Enhabit CAO Collin McQuiddy resigns; CFO Ryan Solomon to assume principal accounting officer role","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Collin McQuiddy resigns as SVP and Chief Accounting Officer effective March 27, 2026.","Resignation is for another career opportunity; no disagreements with company.","CFO Ryan Solomon will perform principal accounting officer functions until a successor is appointed.","Solomon receives no compensation adjustment for the additional duties."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108751,"accession_number":"0001193125-26-064210","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2026-02-23T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Enhabit to be acquired by Kinderhook Industries for $13.80/share, ~$1.1B EV","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Cash consideration of $13.80 per share, a 24.4% premium to Feb 20 close and 33.8% to 60-day VWAP.","Total enterprise value ~$1.1B; transaction expected to close H2 2026, pending stockholder and regulatory approvals.","Company termination fee ~$24.5M; Parent termination fee ~$44.6M under specified conditions.","Equity commitment of $688M from Kinderhook funds; debt financing committed but Merger not conditioned on financing.","Board unanimously approved; stockholders with >2% voting power entered support agreements to vote in favor."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":1.0,"calibrated_materiality_score":1.0,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108750,"accession_number":"0001803737-26-000003","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2026-02-12T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Enhabit collects $43.1M settlement in Delaware fiduciary breach case; shares VitalCaring profit stream","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["Collected $43.1M from former officers Walker, Schuppan, Corey for claims tied to December 2024 judgment finding egregious loyalty breaches.","Settlement proceeds split substantially equally between Enhabit and Encompass Health.","Court-ordered constructive trust gives Enhabit and Encompass Health 43% of VitalCaring Group's ongoing profits and exit proceeds.","Constructive trust against Vistria Group, Nautic Partners, and VitalCaring holding company remains in effect."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":125203,"accession_number":"0001803737-25-000168","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2025-12-09T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Enhabit to present at BofA conference, update on 2026 pricing impacts","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["CEO Barbara Jacobsmeyer and CFO Ryan Solomon to participate in fireside chat at BofA Home Care Conference on Dec 9, 2025.","Discussion includes strategic focus, recent developments, and update to anticipated pricing impacts for 2026.","Investor presentation furnished as Exhibit 99.1, but no specific financial figures provided in filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":125202,"accession_number":"0001803737-25-000163","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2025-11-05T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Enhabit Q3 revenue $263.6M (+3.9% YoY), Adj. EBITDA $27.0M, raises FY guidance midpoints","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $11.1M vs loss of $110.2M; diluted EPS $0.22 (adj. EPS $0.17 vs $0.03).","Home health admissions +3.6% YoY; non-Medicare admissions +10.4%; hospice ADC +12.6%.","Hospice segment Adj. EBITDA $17.2M (+72% YoY); adjusted EBITDA margin 27.3%.","FY25 guidance: revenue $1,058-$1,063M, Adj. EBITDA $106-$109M, Adj. EPS $0.50-$0.56.","Reduced bank debt $15M in Q3; $100M reduction from Q4 2023; leverage ratio 3.9x."],"consensus_eps_estimate":0.1224,"consensus_eps_actual":0.67,"consensus_revenue_estimate":null,"consensus_revenue_actual":789600000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141919,"accession_number":"0001803737-25-000158","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2025-09-29T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Enhabit management to present at Jefferies Healthcare Services Conference; no material new financial data","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["CEO Barbara Jacobsmeyer and CFO Ryan Solomon will participate in a fireside chat on Sept 30, 2025 at 10:55 a.m. CT.","Webcast live and replay available at https://investors.ehab.com.","Investor presentation furnished as Exhibit 99.1 but contains no new financial guidance or material events.","Filing is routine Regulation FD disclosure; no earnings, M&A, or operational updates provided."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141918,"accession_number":"0001803737-25-000148","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2025-08-06T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Enhabit Q2 net rev $266.1M (+2.1% YoY); raises FY2025 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net service revenue $266.1M (+2.1% YoY); net income $5.2M vs loss $0.2M.","Adjusted EBITDA $26.9M (+6.7% YoY); adjusted diluted EPS $0.13 (+85.7%).","Home health admissions +1.3% YoY; hospice ADC +12.3% (6th consecutive quarterly growth).","Raises FY2025 guidance: rev to $1.060-1.073B, Adj. EBITDA to $104-108M, Adj. EPS to $0.47-0.55.","Reduced bank debt $10M in Q2; total $45M prepaid since Q1 2024, lowering interest expense $3.2M."],"consensus_eps_estimate":0.1054,"consensus_eps_actual":0.45,"consensus_revenue_estimate":null,"consensus_revenue_actual":526000000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141917,"accession_number":"0001193125-25-174474","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2025-08-06T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Enhabit CEO Jacobsmeyer to step down by July 2026; board starts successor search","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Barbara Jacobsmeyer will remain President/CEO until successor appointed or July 31, 2026.","Board retained Russell Reynolds to lead search for next CEO.","Retention awards granted: CFO Ryan Solomon $500K, EVP Home Health $390K, GC $390K, HR $350K, EVP Hospice $305K.","Awards are 50% cash and 50% RSUs, vesting Dec 31, 2026 or earlier on certain events.","Transition not due to any disagreement over operations, policies or practices."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159850,"accession_number":"0001803737-25-000121","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2025-06-26T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Enhabit stockholders approve 2025 Equity Plan with 3.3M share reserve","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders approved Enhabit 2025 Equity and Incentive Compensation Plan at June 26 annual meeting.","Plan authorizes up to 3,300,000 shares (net of post-April 29 awards under prior plan) for options, SARs, restricted stock, units, and performance awards.","All 10 director nominees elected; closest vote was Charles M. Elson with 28.9M for vs 2.5M against.","Ratification of PwC as independent auditor passed with 34.4M for (99.4% of votes cast).","Advisory say-on-pay approved with 30.9M votes for (98.8% of votes cast excluding broker non-votes)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159849,"accession_number":"0001803737-25-000113","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2025-06-09T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Enhabit to present at Goldman Sachs Healthcare Conference on June 10, 2025","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["CEO Barbara Jacobsmeyer and CFO Ryan Solomon to participate in fireside chat at Goldman Sachs 46th Annual Global Healthcare Conference.","Chat scheduled for 10 a.m. EDT on June 10, 2025; webcast available on Enhabit's investor relations site.","Investor presentation attached to filing contains standard company overview; no material new financial or strategic updates disclosed.","No earnings guidance, M&A, or leadership changes were announced in the filing or presentation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159848,"accession_number":"0001803737-25-000094","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2025-05-07T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Enhabit Q1 net income $17.8M, adj EBITDA $26.6M; leverage ratio below 4.5x","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net service revenue $259.9M (-1% YoY); home health -5.9%, hospice +20.5%.","Net income $17.8M includes $14.7M gain on sale; adj EBITDA $26.6M (+5.1% YoY).","Reported diluted EPS $0.35; adjusted diluted EPS $0.10.","Hospice average daily census +12.3% YoY; hospice adj EBITDA +64.8%.","Reduced bank debt $25M in Q1; leverage ratio below 4.5x; FY25 guidance reaffirmed."],"consensus_eps_estimate":0.0653,"consensus_eps_actual":0.35,"consensus_revenue_estimate":null,"consensus_revenue_actual":259900000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":178216,"accession_number":"0001803737-25-000068","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2025-03-21T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Enhabit sells Medalogix stake for $21M; proceeds to reduce debt","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sold its investment in Medalogix as part of a private equity-backed combination with Forcura.","Received approximately $21 million in cash proceeds from the transaction.","Proceeds will be used to substantially reduce debt under the company's credit agreement.","Enhabit originally acquired the Medalogix investment in 2019."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":178215,"accession_number":"0001803737-25-000047","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2025-03-05T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Enhabit Q4 net loss $46M on $53.8M goodwill impairment; hospice revenue up 13% YoY; issues FY2025 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss $46.0M (diluted EPS -$0.92) vs loss $6.4M a year ago; includes $53.8M non-cash goodwill impairment.","Adjusted EBITDA $25.1M (0.4% decline); adjusted EPS $0.04 vs $0.06.","Home health revenue $200.4M (-4.3%); hospice revenue $57.8M (+13.1%) with 8.6% ADC growth.","FY2025 guidance: revenue $1.05-1.08B, adj. EBITDA $101-107M, adj. EPS $0.41-0.51.","Reduced bank debt $10M in Q4 ($40M total in 2024); opened three hospice de novo locations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":178214,"accession_number":"0001803737-25-000023","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2025-02-25T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Enhabit nominates former AccentCare CEO Stephan Rodgers to board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Stephan Rodgers, former CEO of AccentCare (home health & hospice), nominated to Enhabit's board.","Rodgers has 25 years of executive experience including at UnitedHealth Group and General Electric.","Rodgers is subject to non-compete through June 30, 2025; election contingent on expiration.","If elected, Rodgers will join board after his non-compete obligations end; annual meeting date not set.","Chairman Jeff Bolton cited Rodgers' industry expertise in overseeing long-term strategies."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194876,"accession_number":"0001803737-24-000203","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2024-12-05T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Enhabit signs multi-year agreement with UnitedHealthcare for home health services, effective Jan 1, 2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["New multi-year agreement with UnitedHealthcare ensures continued in-network access for UHC members.","Agreement takes effect January 1, 2025.","Enhabit to discuss strategic focus and 2025 pricing impacts at BofA Home Care Conference on Dec 10, 2024.","Executives, including incoming CFO Ryan Solomon, will participate in a fireside chat at the conference."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194875,"accession_number":"0001803737-24-000201","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2024-12-04T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Enhabit & Encompass win lawsuit; awarded 43% of VitalCaring Group profits","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["Court found three former officers and Vistria/Nautic aided egregious breaches of duty of loyalty.","Constructive trust: Encompass/Enhabit get 43% of VitalCaring's quarterly profits and 43% of exit proceeds.","Mitigation damages of ~$1.62M and attorneys' fees awarded due to defendants' bad-faith concealment.","Misconduct involved secretly acquiring targets, using confidential info, and poaching employees for VitalCaring."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194874,"accession_number":"0001803737-24-000190","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2024-11-07T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Enhabit (EHAB) appoints Ryan Solomon as CFO effective Dec 9, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Ryan Solomon named CFO; succeeds Crissy Carlisle as part of planned transition.","Base salary $500k, target bonus 70%, $1M restricted stock unit award with 3-year vesting.","Solomon brings 20+ years finance experience; former CFO of AccentCare, Aspirion, Apple Leisure Group.","Compensation includes $300k sign-on lump sum with 2-year clawback and 1.75x base severance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194873,"accession_number":"0001803737-24-000187","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2024-11-06T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Enhabit Q3 net loss $110.2M, adjusted EBITDA $24.5M, guides revenue down","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss $110.2M ($2.20 EPS); adjusted EPS $0.03; revenue $253.6M, down 1.8% YoY.","Home health revenue down 4.7%; hospice revenue up 11.0% on 6.9% higher patient days.","Adjusted EBITDA $24.5M (+5.6% YoY); bank debt reduced by $10M in quarter.","FY2024 guidance cut: revenue $1,031-1,046M (prev $1,050-1,063M), adj. EBITDA $98-102M.","Non-Medicare admissions up 20.1% in home health; hospice average daily census +6.9% YoY."],"consensus_eps_estimate":null,"consensus_eps_actual":-2.2,"consensus_revenue_estimate":null,"consensus_revenue_actual":776600000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211167,"accession_number":"0001803737-24-000164","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2024-08-08T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Enhabit appoints Collin McQuiddy as Senior VP and Chief Accounting Officer","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Collin McQuiddy appointed Senior Vice President and Chief Accounting Officer, effective August 5, 2024.","McQuiddy has over 20 years of public accounting and healthcare experience, including home health and hospice.","Most recently served as Senior Director of Finance for UnitedHealthcare of Louisiana (2020-2024).","Prior roles include Chief Accounting Officer at LHC Group and Senior VP/CAO at Schumacher Clinical Partners.","No material interest, arrangement, or family relationship with Enhabit directors or officers disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211166,"accession_number":"0001803737-24-000154","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2024-08-06T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Enhabit CFO Crissy Carlisle to step down by Dec 31, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CFO Crissy Carlisle's employment ends Dec 31, 2024 or earlier; separation agreement filed as Exhibit 10.1.","Departure not due to any disagreement regarding operations, policies, or practices.","Carlisle will receive base salary through effective date and portion of 2024 annual bonus under Senior Management Bonus Plan.","Company has initiated a comprehensive search for next CFO; CEO Jacobsmeyer praises Carlisle's contributions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211165,"accession_number":"0001803737-24-000151","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2024-08-06T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Enhabit Q2 net loss $0.2M; adj. EBITDA $25.2M; guides 2024 revenue $1.05-1.063B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss $0.2M (diluted EPS $0.00); adj. EPS $0.07; adj. EBITDA $25.2M, up 5.4% YoY.","Home health revenue $210.2M (-1.7%); total admissions +6.4% driven by non-Medicare +25.2%.","Hospice revenue $50.4M (+3.9%); average daily census +2.7% YoY, up sequentially each month since Jan.","2024 guidance: revenue $1.05-1.063B (vs prior $1.076-1.102B), adj. EBITDA $100-106M, adj. EPS $0.19-$0.37.","Reduced bank debt by $15M in quarter; opened one home health de novo in Florida."],"consensus_eps_estimate":null,"consensus_eps_actual":0.0,"consensus_revenue_estimate":null,"consensus_revenue_actual":523000000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211164,"accession_number":"0001803737-24-000133","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2024-07-26T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Enhabit annual meeting: dissident nominee Ohlendorf elected, incumbent La Monica ousted","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Mark Ohlendorf (AREX dissident slate) elected with 20.6M for votes; Susan La Monica (company) not elected with 17.7M for, 24.2M withheld.","Remaining 8 company-nominated directors elected, including top vote-getters Jacobsmeyer (38.6M) and Schochet (38.4M).","Ratification of PwC as auditor passed with 38.8M for; say-on-pay advisory vote approved with 37.1M for.","Turnout 83.87% (42.1M shares of 50.2M outstanding)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.15,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211163,"accession_number":"0001803737-24-000130","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2024-07-25T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Enhabit announces preliminary voting results; AREX Capital nominee elected to board","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Preliminary count shows eight of Enhabit's director nominees elected (Bolton, Brown-Stevenson, Elson, Hoeflinger, Jacobsmeyer, McGuigan, Rush, Schochet).","AREX Capital Management nominee Mark W. Ohlendorf also elected to the board.","Results are preliminary until certified by the independent Inspector of Elections.","Elected directors will serve one-year terms expiring in 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211162,"accession_number":"0001803737-24-000120","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2024-07-15T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Enhabit prelim Q2 2024 adj. EBITDA $24.5-25.0M, reduces debt $15M, admissions up 6.4% YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Adjusted EBITDA guidance of $24.5M-$25.0M for Q2 2024.","Reduced bank debt by $15M, including $10M revolver payment.","Home health admissions up 6.4% year-over-year, driven by non-Medicare.","43% of non-Medicare visits in payor innovation contracts, up from 38% in Q1.","Hospice average daily census grew month-over-month for fifth straight month in June."],"consensus_eps_estimate":null,"consensus_eps_actual":0.0,"consensus_revenue_estimate":null,"consensus_revenue_actual":523000000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":229707,"accession_number":"0001803737-24-000083","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2024-06-11T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Enhabit to present at Goldman Sachs Healthcare Conference; no material updates disclosed","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["CEO Barbara Jacobsmeyer and CFO Crissy Carlisle to participate in fireside chat on June 11, 2024 at 10 a.m. EDT.","Webcast live and replay available at investors.ehab.com.","Investor presentation furnished as Exhibit 99.1; full content not provided in the filing excerpt.","No specific financial or operational updates included in the available information."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":229706,"accession_number":"0001803737-24-000052","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2024-05-08T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Enhabit concludes strategic review without sale; Q1 rev $262.4M, Adj. EBITDA $25.3M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board ends strategic alternatives review, will remain independent; no formal proposals received.","Q1 net income $0.2M, diluted EPS $0.01; adjusted EPS $0.07.","Total admissions up 5.3% YoY; non-Medicare home health admissions up 25.2%.","Reaffirms FY 2024 guidance: revenue $1.076-1.102B, Adj. EBITDA $98-110M.","Four legacy Encompass board members to not stand for election in 2024, reducing board to 9."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248216,"accession_number":"0001803737-24-000036","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2024-03-06T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Enhabit Q4 net loss $6.4M, adjusted EPS $0.06; FY2024 guidance expects $98-$110M EBITDA","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net service revenue $260.6M (-1% YoY); net loss $6.4M vs $95.2M loss in prior year (includes $109M goodwill impairment then).","Home health total admissions +3.9% with non-episodic admissions up 34.2%; revenue down due to payor mix shift of ~$8M.","Hospice revenue +7.8% to $51.1M; adjusted EBITDA doubled to $11.7M on higher revenue per day and cost controls.","FY2024 guidance: net service revenue $1.076B-$1.102B, adjusted EBITDA $98M-$110M, adjusted EPS $0.12-$0.43.","Payor innovation added 11 new Medicare Advantage agreements; 25% of non-episodic visits now under innovation contracts."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":265685,"accession_number":"0001803737-23-000158","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2023-11-07T23:59:59+00:00","items":["1.01","2.02","2.03","7.01","9.01"],"status":"ready","headline":"Enhabit Q3 net loss $2.4M; cuts 2023 guidance; amends credit covenant to 6.75x","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 net service revenue $258.3M (down 2.8% YoY); adjusted EBITDA $23.2M (down 26.8%); adjusted EPS $0.03 vs $0.19.","FY2023 guidance revised: revenue $1,044-1,048M (from $1,057-1,065M), adj. EBITDA $93-98M (from $100-107M).","Credit amendment raises max leverage to 6.75x through Q1 2024; revolver cut from $350M to $220M.","Home health total admissions up 1.6% YoY; non-episodic admissions +33.5%; cost per visit +1.1%.","Hospice revenue down 4% YoY; cost per day up 8.5%; hospice cost per day stabilized QoQ."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.48,"consensus_revenue_estimate":null,"consensus_revenue_actual":785700000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":265684,"accession_number":"0001803737-23-000153","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2023-10-05T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Enhabit schedules Q3 2023 earnings release Nov 7; liquidity ~$80M as of Sept 30","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Q3 2023 results to be released Nov 7; earnings call Nov 8 at 10:00 AM ET.","Total available liquidity as of Sept 30: approximately $80M including cash and equivalents.","Company has not drawn on revolving credit facility in 2023.","Strategic review process ongoing with advisors and prospective partners.","Limited waiver with bank group entered Sept 29 to ensure financial covenant compliance during review."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":265683,"accession_number":"0001803737-23-000150","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2023-10-02T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Enhabit obtains covenant waiver for Q3 2023; revolver cut to $230M","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Limited Waiver exempts compliance with Total Net Leverage Ratio and Interest Coverage Ratio as of Sept 30, 2023 test date.","Revolving loan capacity reduced from $350M to $230M until financial covenant compliance is certified.","Each consenting lender receives a fee of 0.05% of their revolving commitment and outstanding term loans.","Enhabit represents no Default or Event of Default exists as of the waiver effective date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":282900,"accession_number":"0001803737-23-000145","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2023-08-09T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Enhabit Q2 net loss $74.1M; cuts FY23 guidance; plans strategic alternatives process","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 net loss $74.1M ($1.49 diluted loss per share); adjusted EPS $0.04, down 91.5% YoY.","Revenue $262.3M, down 2.1% YoY; adjusted EBITDA $23.9M, down 40.7% YoY.","Full-year 2023 guidance slashed: revenue $1,057-$1,065M (from $1,110-$1,140M), adjusted EBITDA $100-$107M.","Announced intent to launch strategic alternatives process, including potential sale, subject to Tax Matters Agreement conditions with Encompass Health."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.44,"consensus_revenue_estimate":null,"consensus_revenue_actual":527400000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":302247,"accession_number":"0001803737-23-000137","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2023-06-30T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Enhabit shareholders elect 13 directors, ratify PwC, approve say-on-pay at 2023 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Turnout: 46.7M shares (93.13% of outstanding) voted at June 28, 2023 annual meeting.","All 13 director nominees elected; highest votes for (M. McGuigan, B. Schochet) over 39.6M, lowest (L. Shaw) 34.9M.","Ratification of PwC as independent auditor passed with 46.6M votes for, 4,971 against.","Advisory vote on executive compensation approved: 35.0M for, 7.2M against, 57k abstain.","Company will hold annual say-on-pay votes following advisory frequency vote favoring 1 year (40.8M votes)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":302246,"accession_number":"0001803737-23-000110","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2023-06-28T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Enhabit amends credit agreement to raise leverage caps and restrict dividends","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Maximum Total Net Leverage Ratio raised to 5.25x through Dec 2023, stepping to 4.50x by Sep 2024.","New pricing tier added for leverage >4.50x: SOFR margin +2.25%, ABR margin +1.25%.","Restricted payments prohibited before July 1, 2024 unless pro forma leverage ≤4.00x.","Incremental facility ratio condition modified; step-up election available for material acquisitions.","No restricted payments allowed until July 2024 except to borrower/subs or if leverage ≤4.00x."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":302245,"accession_number":"0001803737-23-000075","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2023-05-09T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Enhabit Q1 revenue $265.1M, Adj EBITDA down 46% YoY; reaffirms FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 net service revenue $265.1M (-3.4% YoY); net income $3.2M ($0.05 EPS), adjusted EPS $0.09 vs $0.56 prior.","Adjusted EBITDA $25.3M (9.5% margin) vs $47M (17.1%) YoY; shift to non-episodic and sequestration hurt revenue ~$10M.","Home health admissions up 1.2% YoY on 31.9% surge in non-episodic admissions; hospice admissions down 3.8% YoY.","New national Medicare Advantage payor agreement and two convener agreements effective May 1, 2023.","Full-year 2023 guidance reaffirmed: revenue $1.11-1.14B, Adj EBITDA $125-140M, adjusted EPS $0.50-$0.89."],"consensus_eps_estimate":null,"consensus_eps_actual":0.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":265100000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":302244,"accession_number":"0001803737-23-000050","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K/A","filed_at":"2023-04-14T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Enhabit corrects Q4 2022 results: net loss $94.7M, revenue down 4.7% YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Corrected Q4 2022 net loss of $94.7M ($1.91 loss per diluted share); adjusted EPS $0.17.","Revenue $263.2M, down 4.7% YoY; adjusted EBITDA $30.3M, down 38.2% YoY.","Home health revenue $215.8M (-3.7% YoY); total admissions 50,048 (-1.5% YoY).","Hospice revenue $47.4M (-9.0% YoY); average daily census 3,588 (-1.2% YoY).","FY 2023 guidance: revenue $1.11-1.14B, adj. EBITDA $125-140M, adj. EPS $0.50-0.89."],"consensus_eps_estimate":null,"consensus_eps_actual":0.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":265100000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":302243,"accession_number":"0001193125-23-090235","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K/A","filed_at":"2023-04-04T23:59:59+00:00","items":["2.02","7.01"],"status":"ready","headline":"Enhabit delays FY2022 10-K, discloses $12M AR understatement and material weakness","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Company unable to file FY2022 10-K by due date; goodwill impairment analysis not finalized.","Accounts receivable reserve understated by ~$12M; half from computation failures, half from updated collections assumptions due to Medicare Advantage payor shift.","Material weakness in internal controls over AR allowance methodology; expects disclosure controls and ICFR ineffective as of Dec 31, 2022.","Company does not expect to revise previously issued financial statements or FY2023 guidance.","$2M benefit from 2022 bonus accrual following board approval in Feb 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":321909,"accession_number":"0001193125-23-085654","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2023-03-30T23:59:59+00:00","items":["1.01","5.02","8.01","9.01"],"status":"ready","headline":"Enhabit appoints McGuigan and Schochet to board under cooperation agreement with activist investors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board expanded to 13 directors; Stuart McGuigan and Barry Schochet appointed immediately.","At least four of five legacy Encompass Health directors to step down by 2024 annual meeting.","Cruiser and Harbour Point (owning ~4.7% of shares) entered cooperation agreement with standstill and voting provisions.","Cruiser withdrew its director nomination for 2023 annual meeting.","McGuigan brings CIO experience from State Dept and J&J; Schochet brings healthcare executive background from Tenet."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":321908,"accession_number":"0001803737-23-000010","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2023-02-28T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Enhabit amends executive severance and change-in-control plans, reducing benefits for named officers","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reduces cash severance for CEO from 2.99x to 2.5x base salary; for CFO and EVP from 2x to 1.75x.","Cuts medical/dental/vision continuation for CEO from 36 to 18 months; for others from 24 to 12 months.","Broadens 'Cause' definition to include certain misdemeanors and willful misconduct; modifies 'Good Reason' triggers.","Adds clawback language subject to future company policy, including SEC Rule 10D.","Performance-based equity awards will vest based on actual achievement rather than Committee discretion."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":321907,"accession_number":"0001803737-23-000005","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2023-02-15T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Enhabit Q4 net income down 72.5% to $8.2M; guides FY23 adj EBITDA $125-140M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net service revenue $275.1M (-0.4% YoY); adj EBITDA $40.3M (-17.8% YoY).","GAAP EPS $0.15, adjusted EPS $0.32, down 45.8% YoY.","Home health revenue $220.5M (-1.6%), hospice revenue $54.6M (+4.8%).","Full-year 2023 guidance: revenue $1,110-1,140M, adj EBITDA $125-140M, adj EPS $0.50-0.89.","Completed 3 acquisitions in Q4; added 5 hospice and 2 home health locations."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.81,"consensus_revenue_estimate":null,"consensus_revenue_actual":1071100000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":339989,"accession_number":"0001803737-22-000110","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2022-11-02T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Enhabit Q3 net revenue $265.7M (-3% YoY); cuts FY 2022 guidance across all metrics","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $265.7M (-3% YoY); net income $8.6M (-60.2%); adjusted EPS $0.19 vs $0.50.","Home health revenue $216.3M (-2.2%); hospice revenue $49.4M (-6.4%).","FY 2022 guidance lowered: revenue $1.07-1.08B, Adj. EBITDA $150-155M, Adj. EPS $1.37-1.50.","Completed acquisitions of Caring Hearts and Unity Hospice, adding 5 locations in TX and AZ.","Sequestration, labor costs, and payor mix shift to non-episodic hurt results."],"consensus_eps_estimate":null,"consensus_eps_actual":1.1,"consensus_revenue_estimate":null,"consensus_revenue_actual":808000000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":357308,"accession_number":"0001628280-22-025690","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2022-09-29T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Enhabit General Counsel Chad Knight to step down on Nov 4, 2022","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["General Counsel Chad K. Knight will step down effective November 4, 2022.","Separation agreement includes 15 months of continued base salary and health benefits.","Mr. Knight will receive a pro-rated bonus for FY 2022 under the Senior Management Bonus Plan payable in Q1 2023.","Knight remains subject to existing 12-month noncompete and nonsolicitation covenants."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":357307,"accession_number":"0001803737-22-000076","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2022-08-01T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Enhabit files 8-K reporting Q2 2022 results; specific figures not available in provided text","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Press release and supplemental information furnished as exhibits but not included in the filing text.","Earnings call scheduled for August 2, 2022 at 11:00 a.m. Eastern Time.","Company uses non-GAAP measures including Adjusted EBITDA, Adjusted EPS, and adjusted free cash flow.","Forward-looking statements and risk factors referenced in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":0.93,"consensus_revenue_estimate":null,"consensus_revenue_actual":542300000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":357306,"accession_number":"0001140361-22-025027","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2022-07-05T23:59:59+00:00","items":["1.01","2.03","5.01","5.02","5.03","5.05","8.01","9.01"],"status":"ready","headline":"Enhabit completes spin-off from Encompass Health, trades as EHAB; borrows $570M, appoints two directors","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Spin-off effective July 1, 2022; Encompass shareholders received 1 EHAB share per 2 Encompass shares.","Borrowed $400M Term Loan A and $170M revolver; used $566.6M to pay Encompass.","Board expanded to 11 directors; appointed Tina Brown-Stevenson and Susan La Monica.","Adopted 2022 Omnibus Performance Incentive Plan, Change in Control Benefits Plan, and Executive Severance Plan.","Amended charter to increase authorized shares and effect stock split; adopted new Standards of Business Ethics."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":1.0,"calibrated_materiality_score":1.0,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":375909,"accession_number":"0001140361-22-023677","cik":1803737,"company_name":"Enhabit, Inc.","ticker":"EHAB","form_type":"8-K","filed_at":"2022-06-21T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Enhabit spin-off from Encompass cleared; distribution 1-for-2 on July 1","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Registration statement on Form 10 became effective June 17, 2022.","Encompass shareholders receive 1 share of EHAB for every 2 Encompass shares as of June 24 record date.","Distribution expected at 12:01 a.m. ET on July 1, 2022.","When-issued trading under 'EHAB WI' begins June 23; regular-way 'EHAB' starts July 1 on NYSE."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":706910000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2022-06-21T23:59:59+00:00|375909"}